$4.54 Billion is the total value of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s 88 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| NUVALENT INC | $918,987,373 | +9.0% | 19,991,024 | 0.0% | 20.25% | +12.5% | ||
| GLAUKOS CORPnote 2.750% 6/1 | $426,548,000 | +3.3% | 271,452,000 | 0.0% | 9.40% | +6.7% | ||
| TABULA RASA HEALTHCARE INCnote 1.750% 2/1 | $141,534,635 | +18.0% | 144,516,000 | 0.0% | 3.12% | +21.7% | ||
| NBIX | NEUROCRINE BIOSCIENCES INC | $136,092,825 | +19.3% | 1,209,714 | 0.0% | 3.00% | +23.1% | |
| NATERA INCnote 2.250% 5/0 | $133,525,487 | -9.1% | 101,042,000 | 0.0% | 2.94% | -6.2% | ||
| BROOKDALE SR LIVING INCnote 2.000%10/1 | $114,346,109 | -0.4% | 145,955,000 | 0.0% | 2.52% | +2.7% | ||
| INTERCEPT PHARMACEUTICALS INnote 3.500% 2/1 | $105,134,820 | +11.8% | 98,354,000 | 0.0% | 2.32% | +15.3% | ||
| CPRX | CATALYST PHARMACEUTICALS INC | $95,764,480 | -13.0% | 8,192,000 | 0.0% | 2.11% | -10.2% | |
| LRMR | LARIMAR THERAPEUTICS INC | $66,918,360 | +26.2% | 16,941,357 | 0.0% | 1.47% | +30.2% | |
| IDYA | IDEAYA BIOSCIENCES INC | $61,207,583 | +14.8% | 2,268,628 | 0.0% | 1.35% | +18.5% | |
| NANOSTRING TECHNOLOGIES INCnote 2.625% 3/0 | $53,000,791 | -3.2% | 70,204,000 | 0.0% | 1.17% | -0.1% | ||
| BKD | BROOKDALE SR LIVING INC | $52,493,755 | -1.9% | 12,679,651 | 0.0% | 1.16% | +1.3% | |
| RVMD | REVOLUTION MEDICINES INC | $48,481,409 | +3.5% | 1,751,496 | 0.0% | 1.07% | +6.8% | |
| LIVONGO HEALTH INCnote 0.875% 6/0 | $45,665,200 | +1.1% | 50,000,000 | 0.0% | 1.01% | +4.4% | ||
| SBTX | ARS PHARMACEUTICALS INC | $41,874,564 | -43.6% | 11,077,927 | 0.0% | 0.92% | -41.8% | |
| ICPT | INTERCEPT PHARMACEUTICALS IN | $38,524,136 | +67.6% | 2,077,893 | 0.0% | 0.85% | +72.9% | |
| CABA | CABALETTA BIO INC | $35,616,596 | +17.9% | 2,340,118 | 0.0% | 0.78% | +21.7% | |
| STRUCTURE THERAPEUTICS INCsponsored ads | $31,654,331 | +21.3% | 627,813 | 0.0% | 0.70% | +25.1% | ||
| HEALTH CATALYST INCnote 2.500% 4/1 | $28,517,130 | -0.3% | 30,000,000 | 0.0% | 0.63% | +2.8% | ||
| EWTX | EDGEWISE THERAPEUTICS INC | $22,536,875 | -26.1% | 3,933,137 | 0.0% | 0.50% | -23.7% | |
| DISC MEDICINE INC | $20,201,400 | +5.8% | 430,000 | 0.0% | 0.44% | +9.1% | ||
| DAWN | DAY ONE BIOPHARMACEUTICALS I | $15,582,802 | +2.8% | 1,269,992 | 0.0% | 0.34% | +5.9% | |
| VERASTEM INC | $12,507,688 | +9.3% | 1,538,461 | 0.0% | 0.28% | +13.1% | ||
| DNLI | DENALI THERAPEUTICS INC | $12,274,623 | -30.1% | 594,989 | 0.0% | 0.27% | -28.0% | |
| RVNC | REVANCE THERAPEUTICS INC | $9,978,900 | -54.7% | 870,000 | 0.0% | 0.22% | -53.2% | |
| PRIME MEDICINE INC | $8,445,896 | -34.9% | 885,314 | 0.0% | 0.19% | -32.9% | ||
| FDMT | 4D MOLECULAR THERAPEUTICS IN | $8,274,500 | -29.6% | 650,000 | 0.0% | 0.18% | -27.5% | |
| FUSN | FUSION PHARMACEUTICALS INC | $7,339,800 | -44.3% | 2,823,000 | 0.0% | 0.16% | -42.3% | |
| ALEC | ALECTOR INC | $6,837,644 | +7.8% | 1,055,192 | 0.0% | 0.15% | +11.9% | |
| NEOGENOMICS INCnote 1.250% 5/0 | $5,994,495 | -0.9% | 6,500,000 | 0.0% | 0.13% | +2.3% | ||
| THE ONCOLOGY INSTITUTE INC | $4,704,073 | +154.5% | 3,360,052 | 0.0% | 0.10% | +166.7% | ||
| GENEDX HOLDINGS CORP | $4,564,178 | -38.9% | 1,253,895 | 0.0% | 0.10% | -36.9% | ||
| FHTX | FOGHORN THERAPEUTICS INC | $3,887,625 | -29.0% | 777,525 | 0.0% | 0.09% | -26.5% | |
| ORCHARD THERAPEUTICS PLCspon ads new | $2,443,986 | +48.4% | 316,169 | 0.0% | 0.05% | +54.3% | ||
| AFIB | ACUTUS MED INC | $1,853,519 | -21.6% | 2,660,808 | 0.0% | 0.04% | -18.0% | |
| ANNX | ANNEXON INC | $1,378,035 | -33.0% | 583,913 | 0.0% | 0.03% | -31.8% | |
| NEWAMSTERDAM PHARMA COMPANY*w exp 11/22/202 | $176,295 | -9.1% | 92,787 | 0.0% | 0.00% | 0.0% | ||
| CMAXW | CAREMAX INC*w exp 06/08/202 | $134,400 | -48.2% | 672,000 | 0.0% | 0.00% | -50.0% | |
| THE ONCOLOGY INSTITUTE INC*w exp 11/15/202 | $114,875 | +229.4% | 1,250,000 | 0.0% | 0.00% | +200.0% | ||
| QSIAW | QUANTUM SI INC*w exp 06/10/202 | $90,000 | +17.3% | 333,333 | 0.0% | 0.00% | 0.0% | |
| SIENTRA INC | $27,800 | -5.1% | 10,000 | 0.0% | 0.00% | 0.0% | ||
| SOMALOGIC INC*w exp 08/31/202 | $26,412 | -12.0% | 120,000 | 0.0% | 0.00% | 0.0% | ||
| BFLYWS | BUTTERFLY NETWORK INC*w exp 02/12/202 | $48,547 | -71.9% | 733,333 | 0.0% | 0.00% | -75.0% | |
| SURROZEN INC*w exp 08/01/203 | $6,850 | -25.5% | 166,666 | 0.0% | 0.00% | – | ||
| NUVBWS | NUVATION BIO INC*w exp 07/07/202 | $16,667 | -39.5% | 166,666 | 0.0% | 0.00% | -100.0% |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AERIE PHARMACEUTICALS INC | 36 | Q3 2022 | 3.6% |
| CENTENE CORP DEL | 30 | Q3 2023 | 3.0% |
| BIOCRYST PHARMACEUTICALS INC | 29 | Q3 2023 | 2.2% |
| MOLINA HEALTHCARE INC | 26 | Q3 2022 | 1.7% |
| EHEALTH INC | 25 | Q3 2020 | 2.0% |
| INTERCEPT PHARMACEUTICALS IN | 24 | Q1 2023 | 2.2% |
| MYLAN NV | 23 | Q3 2020 | 6.2% |
| PORTOLA PHARMACEUTICALS INC | 23 | Q1 2019 | 6.0% |
| BROOKDALE SR LIVING INC | 23 | Q3 2023 | 2.2% |
| ALIMERA SCIENCES INC | 23 | Q3 2019 | 0.8% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| DA32 Life Science Tech Acquisition Corp. | August 01, 2023 | 5,145,000 | 91.1% |
| CareMax, Inc. | March 13, 2023 | 18,691,423 | 16.4% |
| CareMax, Inc. | June 02, 2022 | 18,691,423 | 20.7% |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 3 | 2024-03-19 |
| 4 | 2024-03-19 |
| 4 | 2024-03-12 |
| 3 | 2024-03-08 |
| 4 | 2024-02-16 |
| 13F-HR | 2024-02-14 |
| 4 | 2024-02-08 |
| 3 | 2024-02-01 |
| 4 | 2023-11-21 |
| 13F-HR | 2023-11-14 |
View DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.